These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6341642)

  • 21. Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.
    Hayden FG; Sable CA; Connor JD; Lane J
    Antivir Ther; 1996 Jan; 1(1):51-6. PubMed ID: 11322259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.
    Ray CG; Icenogle TB; Minnich LL; Copeland JG; Grogan TM
    J Infect Dis; 1989 May; 159(5):829-36. PubMed ID: 2775346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribavirin for influenza and respiratory syncytial virus infections.
    Lancet; 1983 Sep; 2(8349):554-5. PubMed ID: 6136701
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined action of remantadine (amantadine) and ribavirin on experimental influenza].
    Galegov GA; Knight V; Pushkarskaia NL; Wilson SZ; Couch RB
    Vopr Virusol; 1981; (6):697-701. PubMed ID: 7347232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol.
    Wyde PR; Wilson SZ; Gilbert BE; Smith RH
    Antimicrob Agents Chemother; 1986 Dec; 30(6):942-4. PubMed ID: 3813516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
    Hall CB; McBride JT; Walsh EE; Bell DM; Gala CL; Hildreth S; Ten Eyck LG; Hall WJ
    N Engl J Med; 1983 Jun; 308(24):1443-7. PubMed ID: 6343860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosol therapy of influenza infections of mice and primates with rimantadine, ribavirin, and related compounds.
    Stephen EL; Walker JS; Dominik JW; Young HW; Berendt RF
    Ann N Y Acad Sci; 1977 Mar; 284():264-71. PubMed ID: 101109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
    Cohen A; Togo Y; Khakoo R; Waldman R; Sigel M
    J Infect Dis; 1976 Jun; 133 Suppl():A114-120. PubMed ID: 778307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.
    Hall CB; McBride JT; Gala CL; Hildreth SW; Schnabel KC
    JAMA; 1985 Dec; 254(21):3047-51. PubMed ID: 3903239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for broad-spectrum chemotherapy of serious viral respiratory infections.
    Fedson DS
    JAMA; 1983 May; 249(19):2689-90. PubMed ID: 6842775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of the antiviral preparation ML-76 in influenza].
    Iakushin AI; Trantseeva TB
    Tr Inst Im Pastera; 1985; 63():42-7. PubMed ID: 3916352
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers.
    Magnussen CR; Douglas RG; Betts RF; Roth FK; Meagher MP
    Antimicrob Agents Chemother; 1977 Oct; 12(4):498-502. PubMed ID: 921245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemistry and clinical applications of ribavirin.
    Gilbert BE; Knight V
    Antimicrob Agents Chemother; 1986 Aug; 30(2):201-5. PubMed ID: 2876677
    [No Abstract]   [Full Text] [Related]  

  • 34. Ribavirin.
    Conner CS
    Drug Intell Clin Pharm; 1984 Feb; 18(2):137-8. PubMed ID: 6697874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose-short duration ribavirin aerosol treatment--a review.
    Knight V; Gilbert BE; Wyde PR; Englund JA
    Bull Int Union Tuberc Lung Dis; 1991; 66(2-3):97-101. PubMed ID: 1756300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of oral and aerosol ribavirin regimens in the high risk elderly.
    Bernstein JM; Liss H; Erk SD
    J Clin Pharmacol; 1989 Dec; 29(12):1128-34. PubMed ID: 2693503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol.
    Berendt RF; Walker JS; Dominik JW; Stephen EL
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1069-70. PubMed ID: 879752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribavirin: a clinical overview.
    Fernandez H; Banks G; Smith R
    Eur J Epidemiol; 1986 Mar; 2(1):1-14. PubMed ID: 3021519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report.
    Kirshon B; Faro S; Zurawin RK; Samo TC; Carpenter RJ
    J Reprod Med; 1988 Apr; 33(4):399-401. PubMed ID: 3367344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza.
    Salido-Rengell F; Nasser-Quinones H; Briseno-Garcia B
    Ann N Y Acad Sci; 1977 Mar; 284():272-7. PubMed ID: 360901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.